A pharmaceutical analyst is preparing a dataset for a regulatory audit. The auditor asks the analyst to document not just how the data moved and transformed through the pipeline, but also the original source of the data, who collected it, the methods used, and any custody transfers before it entered the company's systems. Which data governance concept specifically addresses this requirement for documenting the origin and chain of custody of the data?